Aequus Pharmaceuticals Inc. (AQS.V)

CAD 0.01

(0.0%)

Long Term Debt Summary of Aequus Pharmaceuticals Inc.

Aequus Pharmaceuticals Inc.'s latest annual long term debt in 2023 was 583.58 Thousand CAD , down -15.88% from previous year.
Aequus Pharmaceuticals Inc.'s latest quarterly long term debt in 2024 Q1 was 553.37 Thousand CAD , down 0.0% from previous quarter.
Aequus Pharmaceuticals Inc. reported annual long term debt of 693.77 Thousand CAD in 2022, up 580.29% from previous year.
Aequus Pharmaceuticals Inc. reported annual long term debt of 101.98 Thousand CAD in 2021, down -95.31% from previous year.
Aequus Pharmaceuticals Inc. reported quarterly long term debt of 553.37 Thousand CAD for 2024 Q1, down 0.0% from previous quarter.
Aequus Pharmaceuticals Inc. reported quarterly long term debt of 612.23 Thousand CAD for 2023 Q3, down -4.33% from previous quarter.

Annual Long Term Debt Chart of Aequus Pharmaceuticals Inc. (2023 - 2013)

Historical Annual Long Term Debt of Aequus Pharmaceuticals Inc. (2023 - 2013)

Year	Long Term Debt	Long Term Debt Growth
2023	583.58 Thousand CAD	-15.88%
2022	693.77 Thousand CAD	580.29%
2021	101.98 Thousand CAD	-95.31%
2020	2.17 Million CAD	4.95%
2019	2.07 Million CAD	0.0%
2018	- CAD	0.0%
2017	- CAD	0.0%
2016	- CAD	0.0%
2015	- CAD	0.0%
2014	- CAD	0.0%
2013	- CAD	0.0%

Year	Long Term Debt	Long Term Debt Growth
2024 Q2	- CAD	0.0%
2024 Q1	553.37 Thousand CAD	0.0%
2023 Q3	612.23 Thousand CAD	-4.33%
2023 FY	583.58 Thousand CAD	-15.88%
2023 Q4	583.58 Thousand CAD	-4.68%
2023 Q1	667.15 Thousand CAD	-3.84%
2023 Q2	639.92 Thousand CAD	-4.08%
2022 Q1	69.38 Thousand CAD	-31.96%
2022 Q3	677.96 Thousand CAD	1780.46%
2022 Q2	36.05 Thousand CAD	-48.04%
2022 FY	693.77 Thousand CAD	580.29%
2022 Q4	693.77 Thousand CAD	2.33%
2021 Q1	1.94 Million CAD	-10.8%
2021 FY	101.98 Thousand CAD	-95.31%
2021 Q4	101.98 Thousand CAD	-23.45%
2021 Q3	133.22 Thousand CAD	-93.23%
2021 Q2	1.96 Million CAD	1.35%
2020 Q2	2.25 Million CAD	5.54%
2020 Q3	2.28 Million CAD	0.93%
2020 Q4	2.17 Million CAD	-4.57%
2020 FY	2.17 Million CAD	4.95%
2020 Q1	2.14 Million CAD	3.25%
2019 Q3	1.89 Million CAD	0.56%
2019 Q1	426.52 Thousand CAD	0.0%
2019 Q2	1.88 Million CAD	341.41%
2019 Q4	2.07 Million CAD	9.54%
2019 FY	2.07 Million CAD	0.0%
2018 Q4	- CAD	0.0%
2018 Q2	- CAD	0.0%
2018 Q1	- CAD	0.0%
2018 FY	- CAD	0.0%
2018 Q3	- CAD	0.0%
2017 Q4	- CAD	0.0%
2017 Q1	- CAD	0.0%
2017 FY	- CAD	0.0%
2017 Q2	- CAD	0.0%
2017 Q3	- CAD	0.0%
2016 Q1	- CAD	0.0%
2016 Q2	- CAD	0.0%
2016 FY	- CAD	0.0%
2016 Q4	- CAD	0.0%
2016 Q3	- CAD	0.0%
2015 Q1	- CAD	0.0%
2015 Q3	- CAD	0.0%
2015 FY	- CAD	0.0%
2015 Q4	- CAD	0.0%
2015 Q2	- CAD	0.0%
2014 Q4	- CAD	0.0%
2014 Q3	- CAD	0.0%
2014 Q1	- CAD	0.0%
2014 FY	- CAD	0.0%
2013 FY	- CAD	0.0%
2013 Q4	- CAD	0.0%

Peer Long Term Debt Comparison of Aequus Pharmaceuticals Inc.

Name	Long Term Debt	Long Term Debt Difference
CanadaBis Capital Inc.	5.91 Million CAD	90.136%
Decibel Cannabis Company Inc.	32.34 Million CAD	98.196%
Delivra Health Brands Inc.	1.78 Million CAD	67.306%
Entourage Health Corp.	5.79 Million CAD	89.926%
Lifeist Wellness Inc.	868.65 Thousand CAD	32.817%
Cannara Biotech Inc.	39.73 Million CAD	98.531%
Medicure Inc.	229 Thousand CAD	-154.841%
PharmaCielo Ltd.	2.55 Million CAD	77.145%
Rubicon Organics Inc.	- CAD	-Infinity%
BioSyent Inc.	1.03 Million CAD	43.763%
Voyageur Pharmaceuticals Ltd.	40 Thousand CAD	-1358.965%